Loading the security overview…
Where the tokens are
What Recursion Pharmaceuticals has filed with the US Securities and Exchange Commission: annual and quarterly reports, current reports of material events, and the forms insiders file when they trade. Each links to the filing’s page on SEC.gov.
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Sep 21, 2026 | 8-K | Current report | On SEC.gov |
| Aug 5, 2026 | 10-Q | Quarterly report | On SEC.gov |
| Aug 5, 2026 | 8-K | Current report | On SEC.gov |
| Jun 18, 2026 | 8-K | Current report | On SEC.gov |
| May 6, 2026 | 10-Q | Quarterly report | On SEC.gov |
| May 6, 2026 | 8-K | Current report | On SEC.gov |
| Apr 30, 2026 | 8-K | Current report | On SEC.gov |
| Mar 25, 2026 | 8-K | Current report | On SEC.gov |
| Feb 25, 2026 | 10-K | Annual report | On SEC.gov |
| Feb 25, 2026 | 8-K | Current report | On SEC.gov |
| Jan 12, 2026 | 8-K | Current report | On SEC.gov |
| Dec 8, 2025 | 8-K | Current report | On SEC.gov |
| Nov 26, 2025 | 8-K | Current report | On SEC.gov |
| Nov 5, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Nov 5, 2025 | 8-K | Current report | On SEC.gov |
| Oct 29, 2025 | 8-K | Current report | On SEC.gov |
| Aug 5, 2025 | 10-Q | Quarterly report | On SEC.gov |
| Aug 5, 2025 | 8-K | Current report | On SEC.gov |
| Jul 8, 2025 | 8-K | Current report | On SEC.gov |
| Jun 18, 2025 | 8-K | Current report | On SEC.gov |
| Jun 10, 2025 | 8-K | Current report | On SEC.gov |
| May 9, 2025 | 8-K | Current report | On SEC.gov |
| May 5, 2025 | 10-Q | Quarterly report | On SEC.gov |
| May 5, 2025 | 8-K | Current report | On SEC.gov |
| Mar 18, 2025 | 8-K | Current report | On SEC.gov |
| Feb 28, 2025 | 10-K | Annual report | On SEC.gov |
| Feb 28, 2025 | 8-K | Current report | On SEC.gov |
| Jan 13, 2025 | 8-K | Current report | On SEC.gov |
| Dec 17, 2024 | 8-K | Current report | On SEC.gov |
| Dec 3, 2024 | 8-K | Current report | On SEC.gov |
| Nov 20, 2024 | 8-K | Current report | On SEC.gov |
| Nov 13, 2024 | 8-K | Current report | On SEC.gov |
| Nov 13, 2024 | 8-K | Current report | On SEC.gov |
| Nov 6, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Nov 6, 2024 | 8-K | Current report | On SEC.gov |
| Nov 6, 2024 | 8-K | Current report | On SEC.gov |
| Oct 2, 2024 | 8-K | Current report | On SEC.gov |
| Sep 3, 2024 | 8-K | Current report | On SEC.gov |
| Aug 28, 2024 | 8-K | Current report | On SEC.gov |
| Aug 8, 2024 | 10-Q | Quarterly report | On SEC.gov |
| Aug 8, 2024 | 8-K | Current report | On SEC.gov |
| Aug 6, 2024 | 8-K | Current report | On SEC.gov |
| Jun 27, 2024 | 8-K | Current report | On SEC.gov |
| Jun 24, 2024 | 8-K | Current report | On SEC.gov |
| Jun 7, 2024 | 8-K | Current report | On SEC.gov |
| May 24, 2024 | 8-K | Current report | On SEC.gov |
| May 9, 2024 | 10-Q | Quarterly report | On SEC.gov |
| May 9, 2024 | 8-K | Current report | On SEC.gov |
| Apr 16, 2024 | 8-K | Current report | On SEC.gov |
| Feb 29, 2024 | 10-K | Annual report | On SEC.gov |
| Feb 27, 2024 | 8-K | Current report | On SEC.gov |
| Feb 7, 2024 | 8-K | Current report | On SEC.gov |
| Jan 31, 2024 | 8-K | Current report | On SEC.gov |
| Jan 8, 2024 | 8-K | Current report | On SEC.gov |
| Dec 20, 2023 | 8-K | Current report | On SEC.gov |
| Dec 15, 2023 | 8-K | Current report | On SEC.gov |
| Nov 9, 2023 | 10-Q | Quarterly report | On SEC.gov |
| Nov 9, 2023 | 8-K | Current report | On SEC.gov |
| Oct 2, 2023 | 8-K | Current report | On SEC.gov |
| Sep 5, 2023 | 8-K | Current report | On SEC.gov |
Figures describe Recursion Pharmaceuticals shares, not any token. As of Sep 21, 2026, from EDGAR, via Massive. Token issuers file nothing here about the company; their own disclosures are on their issuer pages.